InsidersTradesSigma
인벤테라 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 인벤테라 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 인벤테라 has published 1 insider filings. Market capitalisation: €60.6bn. The latest transaction was filed on 7 April 2026 (Purchase). Among the most active insiders: 유안타케이바이오백신블록버스터사모투자. The full history is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 April 2026
Declarations1 total
368,412 sharesKRXDART:20260407003267
1 of 1 declaration
About 인벤테라
Inventaera is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.